ZA834648B - Triphenylimidazolyloxyalkanoic acids and their derivatives,processes for their preparation and pharmaceutical products containing these compounds - Google Patents

Triphenylimidazolyloxyalkanoic acids and their derivatives,processes for their preparation and pharmaceutical products containing these compounds

Info

Publication number
ZA834648B
ZA834648B ZA834648A ZA834648A ZA834648B ZA 834648 B ZA834648 B ZA 834648B ZA 834648 A ZA834648 A ZA 834648A ZA 834648 A ZA834648 A ZA 834648A ZA 834648 B ZA834648 B ZA 834648B
Authority
ZA
South Africa
Prior art keywords
triphenylimidazolyloxyalkanoic
acids
derivatives
compounds
processes
Prior art date
Application number
ZA834648A
Other languages
English (en)
Inventor
Hans Heiner Lautenschlaeger
Andre Welter
Gerd Hilboll
Johannes Winkelmann
Gerrit Prop
Axel Brekle
Ottfried Zierenberg
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Publication of ZA834648B publication Critical patent/ZA834648B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70—One oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ZA834648A 1982-07-29 1983-06-24 Triphenylimidazolyloxyalkanoic acids and their derivatives,processes for their preparation and pharmaceutical products containing these compounds ZA834648B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3228271A DE3228271A1 (de) 1982-07-29 1982-07-29 Triphenylimidazolyloxyalkansaeuren und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate

Publications (1)

Publication Number Publication Date
ZA834648B true ZA834648B (en) 1984-03-28

Family

ID=6169571

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA834648A ZA834648B (en) 1982-07-29 1983-06-24 Triphenylimidazolyloxyalkanoic acids and their derivatives,processes for their preparation and pharmaceutical products containing these compounds

Country Status (13)

Country Link
US (1) US4460598A (es)
EP (1) EP0104342B1 (es)
JP (1) JPS5951269A (es)
AT (1) ATE25246T1 (es)
DE (2) DE3228271A1 (es)
DK (1) DK158723C (es)
ES (1) ES524512A0 (es)
FI (1) FI79302C (es)
GR (1) GR78654B (es)
IE (1) IE55485B1 (es)
NO (1) NO160579C (es)
PT (1) PT77125B (es)
ZA (1) ZA834648B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3323870A1 (de) * 1983-07-02 1985-01-03 A. Nattermann & Cie GmbH, 5000 Köln Neue imidazol-2-ylthioalkansaeuren und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
US4598149A (en) * 1984-03-02 1986-07-01 Merck & Co., Inc. 3-amino-2-hydroxypropyl of pyrimidin-4-one useful as antihypertensive, cardioprotective, antiarrythmic, and antianginal agents
DE3504678A1 (de) * 1985-02-12 1986-08-14 A. Nattermann & Cie GmbH, 5000 Köln Neue imidazolyl-oxyalkansaeuren und -thioalkansaeuren, ihre derivate und verfahren zu ihrer herstellung
DE3504679A1 (de) * 1985-02-12 1986-08-14 A. Nattermann & Cie GmbH, 5000 Köln Amide der 2-imidazolyloxyalkansaeuren, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3504677A1 (de) * 1985-02-12 1986-08-14 A. Nattermann & Cie GmbH, 5000 Köln Neue imidazol-2-yloxyalkansaeuren und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3504680A1 (de) * 1985-02-12 1986-08-14 A. Nattermann & Cie GmbH, 5000 Köln Neue ether des 2-hydroxyimidazols, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
JPH0680057B2 (ja) * 1986-04-28 1994-10-12 保土谷化学工業株式会社 トリフエニルイミダゾ−ル及びその二量体
NO890522L (no) * 1988-02-25 1989-08-28 Bayer Ag Substituerte imidazolinoner og imidazolinthioner.
US4900744A (en) * 1988-09-14 1990-02-13 E. I. Du Pont De Nemours And Company Antihypercholesterolemic 4,5-diaryl-2-substituted thioimidazoles
US5166214A (en) * 1988-12-05 1992-11-24 Du Pont Merck Pharmaceutical Company Use of imidazoles for the treatment of atherosclerosis
CA2014537A1 (en) * 1989-04-26 1990-10-26 Yoshio Hayashi 4-imidazoline derivatives
US4994482A (en) * 1989-07-31 1991-02-19 Bristol-Myers Squibb Company Arylpyrazol derivatives as anti-platelet agents, compositions and use
US5019572A (en) * 1990-02-07 1991-05-28 Merck & Co., Inc. Imidazole compounds and their use as transglutaminase inhibitors
US5262540A (en) * 1989-12-20 1993-11-16 Bristol-Myers Squibb Company [2(4,5-diaryl-2 oxazoyl substituted phenoxy alkanoic acid and esters
US5152988A (en) * 1990-02-07 1992-10-06 Merck & Co., Inc. Imidazole compounds in compositions and methods in thrombolytic therapy
US5011851A (en) * 1990-02-13 1991-04-30 Bristol-Myers Squibb Co. Imidazole carboxylic acids and esters and inhibition of blood platelet aggregation therewith
CA2036192A1 (en) 1990-02-13 1991-08-14 Nicholas Meanwell Heterocyclic carboxylic acids and esters
GB9019838D0 (en) * 1990-09-11 1990-10-24 Smith Kline French Lab Compounds
US5428041A (en) * 1991-05-31 1995-06-27 The Du Pont Merck Pharmaceutical Company Antihypercholesterolemic bis-trifluoromethyl-substituted imidazolines and derivatives thereof
US5179117A (en) * 1991-12-20 1993-01-12 Du Pont Merck Pharmaceutical Company Antihypercholesterolemic 2-substituted imidazoles
WO1993016674A1 (en) * 1992-02-11 1993-09-02 Smithkline Beecham Corporation CoA-IT AND PAF INHIBITORS
US5254576A (en) * 1992-04-03 1993-10-19 Bristol-Myers Squibb Company Diphenyl-heterocyclic-oxazole as platelet aggregation inhibitors
US5187188A (en) * 1992-04-03 1993-02-16 Bristol-Myers Squibb Company Oxazole carboxylic acid derivatives
US5348969A (en) * 1992-04-03 1994-09-20 Bristol-Myers Squibb Company Diphenyloxazolyl-oxazoles as platelet aggregation inhibitors
US5364875A (en) * 1992-05-11 1994-11-15 The Du Pont Merck Pharmaceutical Company Imidazoles linked to bicyclic heterocyclic groups for the treatment of atherosclerosis
US5310748A (en) * 1992-05-11 1994-05-10 The Du Pont Merck Pharmaceutical Company Imidazoles for the treatment of atherosclerosis
US5362879A (en) * 1993-04-15 1994-11-08 Bristol-Myers Squibb Company 4-5-diphenyloxazole derivatives as inhibitors of blood platelet aggregation
SE527381C3 (sv) * 2003-04-14 2006-03-21 Linnman Elektronik Ab Gemensam fältbuss för överföring av data och energi

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636003A (en) * 1969-11-17 1972-01-18 Geigy Chem Corp Substituted 2-mercaptoimidazole derivatives
DE2934746A1 (de) * 1979-08-28 1981-03-19 A. Nattermann & Cie GmbH, 5000 Köln Oxoimidazolinalkansaeuren, deren salze und ester sowie verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE2950478A1 (de) * 1979-12-14 1981-06-19 A. Nattermann & Cie GmbH, 5000 Köln 4,5-diaryl-4-imidazolin-2-on-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3042466A1 (de) * 1980-11-11 1982-06-16 A. Nattermann & Cie GmbH, 5000 Köln N-substituierte (omega) -(2-oxo-4-imidazolin-l-yl)-alkansaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate

Also Published As

Publication number Publication date
FI832730A0 (fi) 1983-07-28
US4460598A (en) 1984-07-17
ES8404332A1 (es) 1984-04-16
FI79302C (fi) 1989-12-11
GR78654B (es) 1984-09-27
IE831483L (en) 1983-12-29
EP0104342A1 (de) 1984-04-04
PT77125A (en) 1983-08-01
FI832730A (fi) 1984-01-30
FI79302B (fi) 1989-08-31
DE3228271A1 (de) 1984-02-02
EP0104342B1 (de) 1987-01-28
NO832630L (no) 1984-01-30
JPS5951269A (ja) 1984-03-24
JPH0456030B2 (es) 1992-09-07
DK346783D0 (da) 1983-07-28
DK346783A (da) 1984-01-30
PT77125B (en) 1986-01-24
DE3369508D1 (en) 1987-03-05
DK158723C (da) 1990-12-10
NO160579C (no) 1989-05-03
IE55485B1 (en) 1990-09-26
DK158723B (da) 1990-07-09
NO160579B (no) 1989-01-23
ES524512A0 (es) 1984-04-16
ATE25246T1 (de) 1987-02-15

Similar Documents

Publication Publication Date Title
ZA834648B (en) Triphenylimidazolyloxyalkanoic acids and their derivatives,processes for their preparation and pharmaceutical products containing these compounds
DE3370626D1 (en) Imidazolylalkylthienyl-tetrahydropyridazines and process for their preparation
FR2507183B1 (fr) Procede de preparation d'acides 6,8-difluoro-1,4-dihydro-4-oxo-quinoleine-3-carboxyliques
MC1336A1 (fr) Procede pour la preparation de compositions pharmaceutiques
DE3377063D1 (en) Benzisoselenazolones, process for their preparation and pharmaceutical compositions containing them
RO89714A (ro) Procedeu de preparare a unor derivati de 5-metiltiopirimidina
DE2962631D1 (en) Process for the sterilization of pharmaceutical products
DE3165428D1 (en) Substituted azobicyclooctanecarboxylic acids, process for their preparation und pharmaceutical compositions containing them
RO81943A (ro) Procedeu de preparare a unor derivati de piridoxina
RO77553A (ro) Procedeu de preparare a unor acizi tiazol-2-oxamici substituiti
BE881547A (fr) Procede de preparation de d-alpha-amino acides
HUT47430A (en) Process for producing pharmaceutical compositions containing 2-pyrimidinyl-1-piperazine derivatives for treating alcoholizmus
ZA884922B (en) 3-demethyl-4-fluoromevalonic acid derivatives,a process for the preparation thereof,pharmaceutical products based on these compounds,the use thereof,and intermediates
BE884153A (fr) Procede de preparation de compositions pharmaceutiques se desagregeant aisement
DE3371515D1 (en) Cycloalkyl derivatives of benzisoselenazolones, process for their preparation and pharmaceutical compositions containing them
RO81685A (ro) Procedeu de preparare a unor derivati de antrachinonsulfonamide cu formula generala i
DE3261625D1 (en) Tricyclic thiazolyl oxamic acids and derivatives, process for their production, and therapeutic agents containing them
HUT35958A (en) Process for the production of pharmaceutical preparation suitable for therapic treatment of rheumatic diseases
DE3378413D1 (en) Spiro-2-aza-alkane-3-carbonitriles, process for their preparation and their use
DE3277971D1 (en) Acylamino-4-aza-1-adamantanes, process for their preparation and their therapeutic use
RO79956A (fr) Procede de preparation des 3-halocephalosporines
PT74744A (fr) Procede de preparation de derives de phenethanolamine et de compositions pharmaceutiques les contenant
DE2962739D1 (en) Process for the purification of chenodesoxycholic acid and products obtained by this process
RO78492A (ro) Procedeu pentru prepararea unor derivati ai acizilor 1,3,4-tiadiazoli-2-carboxilici
IL59768A (en) Prostaglandin derivatives of the 6-keto-pge1 series,process for their preparation and pharmaceutical compositions containing them